mesenchymal stem cells

[Scientific Reports] Researchers presented an effective strategy to reverse aging of mouse bone marrow MSCs by restoring their mitochondrial functionality using photobiomodulation therapy.

[Hope Biosciences] Hope Biosciences Stem Cell Research Foundation has received FDA authorization for a Phase II clinical trial to assess the efficacy and safety of multiple intravenous infusions of allogeneic adipose-derived MSCs in improving activities of daily living and quality of life in subjects with Parkinson’s Disease.

[Biochimica Et Biophysica Acta-Reviews On Cancer] Investigators elaborate on all mentioned contradictory data and provides a realistic, current clinical perspective on MSCs' potential in glioblastoma treatment.

[Biomedicine & Pharmacotherapy] The authors point out the dynamic potential of CSCs and other stem cells types in colorectal cancer (CRC) treatment personalization as well as, in the improvement of current treatment approaches, opting to a higher therapeutic rate, improved prognosis, survival and quality of life for CRC patients.

[NPJ Regenerative Medicine] Scientists summarize the use of different human cell populations for preclinical and clinical tissue-engineered skin substitutes under research, remarking their strengths and limitations and discuss the future perspectives, which could be useful for wound healing purposes.

[PLOS One] Scientists evaluated the in vitro anti-viral activities of combinations of certain commercially available drugs that have recently formed part of COVID-19 therapy. These drugs were mixed at specific ratios and evaluated for their safe use based on the cytotoxicity concentration values of human umbilical cord mesenchymal stem cells.